Small Diagnostics Company Aims To Change Lab Field Testing (OTC:BMGP) |
![]() |
![]() |
By M.E.Garza | |
Wednesday, 14 October 2009 03:00 | |
![]()
Biomagnetics Diagnostics Corp. (OTC:BMGP) is a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing. The company has made it one of their goals to provide innovative products to meet this demand and to deploy their testing equipment and technologies in the field as well as in the clinical setting for a wide variety of pathogens. Joe Noel, who introduced many investors to BioElectronics Corporation, tells us about this intriguing penny stock play within the diagnostics space. A special, in-depth audio interview can be heard below (click on the player under the image):
"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'. Add this page to your favorite Social Bookmarking websites ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |